LYRA

PINK Lyra Therapeutics, Inc.
Sep 30, 2026 · 3:47 PM ET DELAYED Market Open

$0.0300 ↓ -0.1700 (-85.00%) Trading Down from the previous close of $0.2000, and at the day’s high of $0.0300

YTD change
-99.03%
vs 20-day SMA
-74.96%
vs 200-day SMA
-97.98%

Price ranges

Previous day
$0.2000 $0.2000
open $0.2000 close $0.2000
+$0.0000 (+0.00%)
Today
$0.0300 $0.0300
open $0.0300 now $0.0300
+$0.0000 (+0.00%)
Past week
$0.0300 $0.2000
from $0.2000 now $0.0300
-$0.1700 (-85.00%)
Past month
$0.0004 $0.2500
from $0.2500 now $0.0300
-$0.2200 (-88.00%)
This year
$0.0004 $3.9400
from $3.0800 now $0.0300
-$3.0500 (-99.03%)

Price & Performance

-0.29 (-59.20%) / 6M

$-0.0639$0.2470$0.5580$0.8689Mar 30Jun 10Sep 25

Signals & Sentiment

Momentum, market sentiment, and recent alerts

N/A
  • The stock is 100.0% away from all-time highs of $1,100.0000
  • LYRA is down 99% since the beginning of the year
  • LYRA is down 100% over the past 12 months
  • LYRA is down 88% over the past 1 month
  • 0% of all LYRA investors are betting against LYRA

LYRA reads n/a: price sits below both the 20- and 200-day averages, the 12-month move is -96.9%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-3.9163
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $14.7M
Beta 2.66

Balance sheet & scale

IncomeN/A
Revenue$398.0K
Cash$15.9M
Debt$30.3K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangePINK
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $53.1K

Lyra Therapeutics, Inc. is a clinical-stage therapeutics company. It develops novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat (ENT) diseases. The firm's proprietary XTreo platform delivers medicines directly to targeted sites. The company was founded by Carmichael S. Roberts, George M. Whitesides, and Robert S. Langer on November 21, 2005 and is headquartered in Watertown, MA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $423.64 +1.32%
MRNA Moderna, Inc. $203.46 +3.13%
RVMD Revolution Medicines, Inc. $204.48 +1.36%
ROIV Roivant Sciences Ltd. $36.50 -1.30%
BNTX BioNTech SE Sponsored ADR $98.57 -0.51%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.